Haoyunbang Partners with Shandong University Reproductive Hospital to Build an Integrated Medical-Grade Fertility Platform

Through artificial insemination, Andy Lau and Carol Chu have successfully conceived their second child. In recent years, assisted reproductive technology has gradually come into public view, and the integration of "Internet + Assisted Reproduction" has brought convenience to many families in need.

On the morning of March 30, International Physicians’ Day,Haoyunbang, a platform specializing in reproductive medicine, signed a strategic cooperation agreement with the Reproductive Hospital Affiliated to Shandong University in Jinan. The two parties will launch a series of integrated online and offline fertility management projects, establishing a one-stop, medical-grade preconception care platform that seamlessly connects online and offline services.

GoodYunbang Founder Huang Sen and Shanxi University Reproductive Hospital Director Ma Jinlong Sign Strategic Cooperation Agreement

This strategic collaboration will initially focus on the field of tiered diagnosis and treatment for specific vertical disease areas. Both parties are committed to delivering high-quality services to help users preparing for pregnancy efficiently manage their preconception journey, enabling convenient access to medical, health, and lifestyle support at each stage. Furthermore, the partnership aims to provide a precise communication platform for reproductive medicine professionals, fostering academic exchange on disease diagnosis and treatment.

In the future,The collaboration between Haoyunbang and Shandong University Reproductive Hospital will also cover smart hospital development, joint medical project development, establishment of preconception care centers, research data collection and analysis, and co-branded marketing.

At the signing ceremony, Dr. Ma Jinlong, Director of Shandong University Reproductive Hospital, stated, “Through our collaboration with Haoyunbang, we aim to effectively help patients with reproductive disorders enhance their understanding of these conditions, gain rapid access to standardized diagnosis and treatment services, improve their healthcare experience, and achieve successful pregnancies sooner.”

Huang Sen, founder of Haoyunbang, mentioned:HaoYunBang’s upcoming business strategy will focus on solution provision. By integrating the highest-quality domestic medical and health resources, HaoYunBang aims to deliver comprehensive, one-stop, medically-grade, and personalized services to users seeking assistance during their preconception journey.Such medical services, which can vary in depth and complexity, must be provided by hospitals with proper medical qualifications. Since its inception, Haoyunbang has maintained a cautious and politely declining stance toward collaborations with low-end private hospitals of uneven quality. It strictly screens service providers, prioritizing partnerships with reputable public tertiary A-grade hospitals and top-tier joint-stock hospitals.

Shandong University Reproductive Hospital is one of China’s premier reproductive healthcare institutions. Over more than two decades of exploration and practice, it has established a comprehensive, scientific, and advanced system encompassing both basic research and clinical treatment for infertility and sterility in the field of reproductive medicine. Through this medical-network collaboration, the hospital is poised to deliver high-quality diagnostic and therapeutic services to individuals preparing for pregnancy, thereby driving breakthrough improvements in efficiency across the healthcare industry.

Dean Ma Jinlong of Shandong University Reproductive Hospital stated that the hospital has always placed great emphasis on information technology infrastructure, achieving significant results. At Shandong University Reproductive Hospital, patients do not face difficulties in securing appointments, primarily due to two reasons. On one hand, the hospital employs over 100 physicians, ensuring adequate service capacity from medical staff. On the other hand, the hospital does not impose caps on appointment numbers; as long as patients register and book an appointment, they will receive care from a professional physician at the associate chief physician level or above.

This collaboration between Haoyunbang and Shandong University Reproductive Hospital not only allows traditional hospitals to reap the branding benefits of the rapid development of the internet, but also enables emerging mobile healthcare services to establish a tangible offline presence.

Wen Huisheng, Partner at Gene Capital, an investor in Haoyunbang, stated: “The recently released 13th Five-Year Plan, healthcare reform initiatives, and guidelines on tiered diagnosis and treatment all emphasize encouraging Internet Plus Healthcare and telemedicine to deepen reforms. By leveraging the internet as a channel, we aim to improve previous medical consultation processes and truly build a vertical ecosystem in the therapeutic field. Given the high barriers, prolonged course of disease, and need for deep trust between doctors and patients in the reproductive health sector, collaborating with top-tier hospitals through intelligent internet-based disease management systems can provide perfectly complementary services to patients.”

It is understood that Haoyunbang is a mobile health enterprise focused on the field of reproductive medicine, founded in 2014 by Huang Sen, a medical professional from Peking University. Since securing millions in angel investment in 2014, the company has experienced rapid growth. Its highly professional and medically rigorous product design has allowed it to stand out among numerous preconception health products, quickly accumulating a large base of reproductive specialists (primarily physicians from public Grade 3A hospitals) as well as users seeking preconception care, particularly those facing infertility challenges. This has enabled Haoyunbang to emerge as a latecomer leader in the mobile health sector. In October 2015, the company secured tens of millions of RMB in Series A financing, with investors including Gene Capital, Sinopharm Capital, and Puhua Capital. (For details, please refer to the VCBeat article “Haoyunbang: Bringing the Clinical Pathway for Infertility to Your Smartphone》。）

The strategic partner in this collaboration, Reproductive Hospital Affiliated to Shandong University, was formerly the Center for Reproductive Medicine at Shandong Provincial Hospital. Founded in 1987 by Professor Chen Zijiang, a renowned leading expert in the field of reproductive medicine, it was among the first 13 medical institutions in China to receive technical accreditation from the Ministry of Health. It serves as the National Engineering Research Center for Assisted Reproduction and Eugenics. Shandong Province’s only human sperm bank is also housed within the hospital. Each year, it attracts more than 200,000 patients with reproductive disorders from across China and performs over 10,000 assisted reproductive technology (ART) cycles. The success rate of its in vitro fertilization (IVF) procedures is approximately 55%, significantly higher than the national average and reaching an advanced international level.According to statistics,2015year, the outpatient volume of Shandong University Reproductive Hospital exceeded 40person-times, and successfully assisted in 2 pregnancies10,000 cases.

Finally, startup teams seeking media coverage are welcome to contact us at:tg@vcbeat.top